Earlier this week, the U.S. Food and Drug Administration (FDA) refused a labeling request by Bayer AG, a German aspirin manufacturer.  The FDA restricted Bayer AG from labeling their product’s value of preventing heart attacks and strokes in people who have not had cardiovascular disease. The effects of aspirin Aspirin is a product noted for … Continue reading FDA Refuses Aspirin Labeling Request by Bayer AG